These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 8342244)
1. Outcome of patients with pre-existing hepatitis B virus infection following renal transplant. Malhotra KK; Dash SC; Sharma RK; Dhawan IK; Mehta SN; Tiwari SC; Agarwal SK; Bhuyan UN Trop Gastroenterol; 1993; 14(1):16-20. PubMed ID: 8342244 [TBL] [Abstract][Full Text] [Related]
2. Renal transplant in hepatitis B and C positive patients--a ten years experience. Rathod JR; Sirsat RA; Shah BV J Assoc Physicians India; 2002 Jun; 50():766-70. PubMed ID: 12240839 [TBL] [Abstract][Full Text] [Related]
3. An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation. Ben-Ari Z; Broida E; Kittai Y; Chagnac A; Tur-Kaspa R Am J Gastroenterol; 2000 Dec; 95(12):3579-83. PubMed ID: 11151895 [TBL] [Abstract][Full Text] [Related]
4. [Chronic hepatitis B infection and liver failure following kidney transplantation]. Christen R; Blumberg A; Pirovino M Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2523-5. PubMed ID: 8571106 [TBL] [Abstract][Full Text] [Related]
5. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients. Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918 [TBL] [Abstract][Full Text] [Related]
6. Renal transplantation in hepatitis B carriers: comparison of azathioprine- and cyclosporine-treated recipients. Lai MK; Huang CC; Chu SH; Chuang CK; Fong MT Clin Transpl; 1989; ():281-6. PubMed ID: 2487573 [TBL] [Abstract][Full Text] [Related]
7. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment. Kim JA; Huh W; Lee KW; Kim SJ; Kim YG; Kim DJ; Joh JW; Oh HY Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection in allogeneic bone marrow transplantation. Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543 [TBL] [Abstract][Full Text] [Related]
9. HBsAg as predictor of outcome in renal transplant patients. Ridruejo E; Brunet Mdel R; Cusumano A; Diaz C; Michel MD; Jost L; Jost L; Mando OG; Vilches A Medicina (B Aires); 2004; 64(5):429-32. PubMed ID: 15560544 [TBL] [Abstract][Full Text] [Related]
10. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients]. Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007 [TBL] [Abstract][Full Text] [Related]
11. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299 [TBL] [Abstract][Full Text] [Related]
12. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors. Sumethkul V; Ingsathit A; Jirasiritham S Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516 [TBL] [Abstract][Full Text] [Related]
13. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates]. Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054 [TBL] [Abstract][Full Text] [Related]
14. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage. Fabrizio F; Bunnapradist S; Martin P J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection. Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932 [TBL] [Abstract][Full Text] [Related]
18. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings. Veroux M; Puliatti C; Macarone M; Cappello D; Gagliano M; Spataro M; Di Mare M; Giuffrida G; Veroux P Transplant Proc; 2005; 37(6):2467-8. PubMed ID: 16182711 [TBL] [Abstract][Full Text] [Related]
19. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502 [TBL] [Abstract][Full Text] [Related]
20. Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis. Chan HL; Chui AK; Lau WY; Chan FK; Hui AY; Rao AR; Wong J; Lai EC; Sung JJ Clin Transplant; 2004 Jun; 18(3):295-300. PubMed ID: 15142051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]